CKD Itch

CKD-associated pruritus (CKD-aP)

Chronic kidney disease-associated pruritus (CKD-aP) is a common but often overlooked condition that causes persistent itching in patients with CKD, significantly affecting their quality of life. Despite its impact, CKD-aP is frequently underreported and underdiagnosed, but with the right knowledge and treatment, patient comfort can be improved.
This non-promotional eLearning course has been sponsored by CSL Vifor.
CSL Vifor has reviewed the course for technical accuracy and ABPI code compliance.
MED-UK-NP-2500017.
Date of prep: August 2025
Format

Self-Paced Online
Course

Duration

1 hour

Audience

Healthcare professionals

Featuring

Prof James Burton & Kathrine Parker

About the course

Chronic kidney disease-associated pruritus (CKD-aP) is a common but frequently under-recognised condition that affects many people with CKD, especially those receiving dialysis. Though often overlooked, CKD-aP has been linked to poorer sleep, mental health challenges, and reduced quality of life.

This course is designed for healthcare professionals who want to improve patient care by recognising and managing CKD-aP more effectively. By enhancing your ability to spot the signs early and support symptom relief, you can play a key role in improving the day-to-day experience of your patients. Don't let CKD-aP remain in the background—equip yourself to address it with confidence.

Advance your knowledge

Improve patient outcomes

Earn a certificate

This non-promotional eLearning course has been sponsored by CSL Vifor.
CSL Vifor has reviewed the course for technical accuracy and ABPI code compliance.

Learning objectives

By the end of this course, you will be able to:
  • Recognise CKD-aP as a common but underdiagnosed condition that significantly affects the quality of life of patients with CKD, particularly those on dialysis.
  • Evaluate the physical, psychological, and social consequences of untreated CKD-aP, including poor sleep, fatigue, depression, social withdrawal, and reduced dialysis adherence.
  • Understand the multifactorial pathophysiology of CKD-aP, including uraemic toxins, peripheral neuropathy, opioid receptor imbalances, and immune system dysregulation.
  • Identify CKD-aP and utilise validated assessment tools such as the WI-NRS, Skindex-10, and the 5-D Itch Scale to determine its severity.

Contents